CY1115505T1 - COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS - Google Patents
COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODSInfo
- Publication number
- CY1115505T1 CY1115505T1 CY20141100678T CY141100678T CY1115505T1 CY 1115505 T1 CY1115505 T1 CY 1115505T1 CY 20141100678 T CY20141100678 T CY 20141100678T CY 141100678 T CY141100678 T CY 141100678T CY 1115505 T1 CY1115505 T1 CY 1115505T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- antibodies against
- cytarotoxic
- conjected
- factor
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση αφορά συνθέσεις που περιλαμβάνουν αντισώματα εναντίον CD79b συζευγμένα με παράγοντα αναστολής αύξησης ή κυτταροτοξικό παράγοντα χρήσιμα για την θεραπευτική αγωγή αιμοποιητικού όγκου σε θηλαστικά και μεθόδους χρήσης αυτών των συνθέσεων υλικού για τον ίδιο σκοπό.The present invention relates to compositions comprising antibodies against CD79b conjugated to growth inhibitor or cytotoxic agent useful for the treatment of mammalian hematopoietic tumor and methods of using these material compositions for the same purpose.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52084203A | 2003-11-17 | 2003-11-17 | |
US53242603A | 2003-12-24 | 2003-12-24 | |
EP09004091.6A EP2161283B1 (en) | 2003-11-17 | 2004-11-16 | Compositions comprising antibodies against CD79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1115505T1 true CY1115505T1 (en) | 2017-01-04 |
Family
ID=58461571
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100512T CY1115252T1 (en) | 2003-11-17 | 2014-07-08 | ANTISOMA VS CD22 FOR THERAPEUTIC TREATMENT OF BLOOD ORIGIN |
CY20141100678T CY1115505T1 (en) | 2003-11-17 | 2014-08-22 | COMPOSITIONS INCLUDING ANTIBODIES AGAINST CD79b CONJECTED WITH ANTI-GROWTH AGENTS OR CYTAROTOXIC FACTOR AND METHODS |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20141100512T CY1115252T1 (en) | 2003-11-17 | 2014-07-08 | ANTISOMA VS CD22 FOR THERAPEUTIC TREATMENT OF BLOOD ORIGIN |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1115252T1 (en) |
-
2014
- 2014-07-08 CY CY20141100512T patent/CY1115252T1/en unknown
- 2014-08-22 CY CY20141100678T patent/CY1115505T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1115252T1 (en) | 2017-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121162T1 (en) | M-CSF-SPECIAL MONOCLONIC ANTIBODY AND ITS USE | |
CY1120070T1 (en) | METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates | |
CY1112055T1 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG TUMOR | |
CY1119722T1 (en) | CREATION AND DESCRIPTION OF COMPLETELY HUMAN TREATMENT ANTIBODIES TAKEN INTO HUCAL GOLD SPECIAL FOR HUMAN CD38 | |
CY1118668T1 (en) | Immunoconjugates Against Folic Acid Receptors 1 and their uses | |
CY1117124T1 (en) | HUMANIZED ANTI-β7 ANTAGONISTS AND THEIR USES | |
CY1110759T1 (en) | SNOWLINE DIFFERENCES AND THEIR USES | |
CY1109888T1 (en) | PRODUCTS OF 2,4-PYRIMIDINAMINE COMPOUNDS AND THEIR USES | |
CY1115580T1 (en) | COMPOSITION AND ANTI-VIVAL ACTIVITY OF SUBSTITUTED AZAIDOLOLOXIC Piperazine Derivatives | |
CY1113984T1 (en) | DM1 conjugate conjugate products with TRASTUZUMAB antibody, CONNECTED THROUGH NON-EXTRACTIVE CONNECTOR AND USE IN TREATMENT TREATMENT | |
CO5611160A2 (en) | CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES | |
CY1112383T1 (en) | Inhibitors of Protein Activation of 5-Lipoxygenase (FLAP) | |
CY1108344T1 (en) | EXPRESSION BODIES CONTAINING THE MCMV IE2 PROPERTY | |
CY1112297T1 (en) | Heterocyclic Suspensions of MEK and Methods of Using These | |
CR9763A (en) | USE OF A SINGLE DOSE OF SPECIFIC UNION MOLECULES CD20 | |
EA201201533A1 (en) | PRLR-SPECIFIC ANTIBODY AND ITS APPLICATIONS | |
CY1112862T1 (en) | UNIQUE ANTIQUES SHRAPS USEFUL AS THERAPEUTIC | |
CY1113094T1 (en) | NAVIGATED GUIDES AGAINST NOGO | |
CY1108722T1 (en) | Polycyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes | |
CY1106992T1 (en) | WALNUT F AND RELATED COMPOUNDS | |
CY1105137T1 (en) | DERIVATIVES OF AMINOCYCLOHEXYL ETHERS AND THEIR USES | |
CY1106444T1 (en) | 17B-NITRO-11B-ARYLOSTEPOIDES AND THEIR DERIVATIVES AS HORMONE AGENTS OR ANTAGONISTS | |
PT2161283E (en) | Compositions comprising antibodies against cd79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin | |
DE60002855D1 (en) | Haloalkoxy IMIDAZONAPHTHYRIDINE | |
AR063507A1 (en) | DERIVATIVES OF FLUORENE, COMPOSITIONS THAT CONTAIN THEM AND USE AS ANTI-BANERIGENS |